Suppression of neuropeptide by botulinum toxin improves imiquimod-induced psoriasis-like dermatitis via the regulation of neuroimmune system
Authors:
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 101 (1) , 58-68
Abstract
No abstract availableKeywords
Funding Information
- Gunma University
This publication has 48 references indexed in Scilit:
- T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular ComorbiditiesFrontiers in Immunology, 2018
- Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatmentTherapeutic Advances in Chronic Disease, 2018
- Novel insights into the pathogenesis of psoriasisClinical Immunology, 2018
- The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation InjuryAmerican Journal of Clinical Dermatology, 2016
- PsoriasisThe Lancet, 2015
- Cytokines in psoriasisCytokine, 2015
- The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responsesTrends in Immunology, 2013
- New insights of T cells in the pathogenesis of psoriasisCellular & Molecular Immunology, 2012
- Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokinesCurrent Rheumatology Reports, 2007
- Unilateral remission of psoriasis following traumatic nerve palsyBritish Journal of Dermatology, 2005